- Previous close
140.74 - Open
140.78 - Bid --
- Ask --
- Day's range
139.14 - 141.51 - 52-week range
75.36 - 153.93 - Volume
357,021 - Avg. Volume
753,010 - Market cap (intra-day)
7.592B - Beta (5Y monthly) 0.98
- PE ratio (TTM)
96.09 - EPS (TTM)
1.45 - Earnings date 5 Nov 2024
- Forward dividend & yield --
- Ex-dividend date 23 Nov 2012
- 1y target est
155.57
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
www.masimo.com3,800
Full-time employees
30 December
Fiscal year ends
Healthcare
Sector
Medical Devices
Industry
Recent news: MASI
View more
Performance overview: MASI
Trailing total returns as of 25/10/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: MASI
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: MASI
View moreValuation measures
Market cap
7.53B
Enterprise value
8.26B
Trailing P/E
95.74
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
3.78
Price/book (mrq)
5.50
Enterprise value/revenue
4.09
Enterprise value/EBITDA
36.42
Financial highlights
Profitability and income statement
Profit margin
3.94%
Return on assets (ttm)
3.00%
Return on equity (ttm)
5.93%
Revenue (ttm)
2.02B
Net income avi to common (ttm)
79.4M
Diluted EPS (ttm)
1.45
Balance sheet and cash flow
Total cash (mrq)
129.6M
Total debt/equity (mrq)
63.08%
Levered free cash flow (ttm)
120.2M